PubMed · 39978341
Sustained NF-κB activation allows mutant alveolar stem cells to co-opt a regeneration program for tumor initiation.
Abstract
Disruptions to regulatory signals governing stem cell fate open the pathway to tumorigenesis. To determine how these programs become destabilized, we fate-map thousands of murine wild-type and KrasG12D-mutant alveolar type II (AT2) stem cells in vivo and find evidence for two independent AT2 subpopulations marked by distinct tumorigenic capacities. By combining clonal analyses with single-cell transcriptomics, we unveil striking parallels between lung regeneration and tumorigenesis that implicate Il1r1 as a common activator of AT2 reprogramming. We show that tumor evolution proceeds through the acquisition of lineage infidelity and reversible transitions between mutant states, which, in turn, modulate wild-type AT2 dynamics. Finally, we discover how sustained nuclear factor κB (NF-κB) activation sets tumorigenesis apart from regeneration, allowing mutant cells to subvert differentiation in favor of tumor growth.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Frances J England, Ignacio Bordeu, Minn-E Ng, JaeHak Bang, Bumsoo Kim, Jinwook Choi, Erik C Cardoso, Bon-Kyoung Koo, Benjamin D Simons, Joo-Hyeon Lee. 2025-02-19. Sustained NF-κB activation allows mutant alveolar stem cells to co-opt a regeneration program for tumor initiation.. https://doi.org/10.1016/j.stem.2025.01.011
Cite the original work for its findings. Save a collection to share your selection of sources.